BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2300478
,
SLC12A1
,
T cell differentiation
,
Allergy to pollen
,
Pancreas
,
Ciprofibrate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
COPS2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
T Lymphocyte (regulatory) of peripheral blood
B lymphocyte (naive) of spleen
T Lymphocyte (CD8+) of peripheral blood
B lymphocyte (IgM memory) of spleen
Dendritic (plasmacytoid) cell
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
COPS2 Antagonizes OCT4 to Accelerate the G2/M Transition of Mouse Embryonic Stem Cells.
The reduced form of the antibody CH2 domain.
Developability Assessment of an Isolated CH2 Immunoglobulin Domain.
High-level expression of human CH2 domain from the Fc region in Pichia pastoris and preparation of a…
Exercise training reverses cancer-induced oxidative stress and decrease in muscle COPS2/TRIP15/ALIEN…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for COPS2
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ